Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study

Even though 80% of patients with High-Grade Serous Ovarian Cancer respond to standard first-line chemotherapy, a majority of them could relapse in the following five years due to a resistance to platinum. Human Epididymis protein 4 (HE4) is one of the most promising markers in predicting platinum th...

Descripción completa

Detalles Bibliográficos
Autores principales: Plotti, Francesco, Terranova, Corrado, Guzzo, Federica, De Cicco Nardone, Carlo, Luvero, Daniela, Bartolone, Martina, Dionisi, Camilla, Benvenuto, Domenico, Fabris, Silvia, Ciccozzi, Massimo, Di Donato, Violante, Panici, Pierluigi Benedetti, Angioli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827362/
https://www.ncbi.nlm.nih.gov/pubmed/33435590
http://dx.doi.org/10.3390/biomedicines9010055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827362/
https://www.ncbi.nlm.nih.gov/pubmed/33435590
http://dx.doi.org/10.3390/biomedicines9010055

Ejemplares similares